GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLscience Co Ltd (XKRX:239610) » Definitions » Debt-to-Equity

HLscience Co (XKRX:239610) Debt-to-Equity : 0.01 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is HLscience Co Debt-to-Equity?

HLscience Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩0 Mil. HLscience Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩450 Mil. HLscience Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₩94,544 Mil. HLscience Co's debt to equity for the quarter that ended in Dec. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for HLscience Co's Debt-to-Equity or its related term are showing as below:

XKRX:239610' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.01
Current: 0.01

During the past 10 years, the highest Debt-to-Equity Ratio of HLscience Co was 0.01. The lowest was 0.00. And the median was 0.00.

XKRX:239610's Debt-to-Equity is ranked better than
99.88% of 816 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs XKRX:239610: 0.01

HLscience Co Debt-to-Equity Historical Data

The historical data trend for HLscience Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLscience Co Debt-to-Equity Chart

HLscience Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.01

HLscience Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.01 0.01 0.01

Competitive Comparison of HLscience Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, HLscience Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLscience Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HLscience Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where HLscience Co's Debt-to-Equity falls into.


;
;

HLscience Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

HLscience Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

HLscience Co's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLscience Co  (XKRX:239610) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


HLscience Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of HLscience Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


HLscience Co Business Description

Traded in Other Exchanges
N/A
Address
36, Dongsanjae-gil, Bongdam-eup, Hwaseong-si, Gyeonggi-do, Anyang-si, KOR
HLscience Co Ltd is engaged in researching and developing bio healthcare products. It offers products including Dr. Super Khan, Red Cleo, Dr. Spirulina, Dr. Circuone, and Super We Force.

HLscience Co Headlines

No Headlines